Oxalate is a normal constituent of human urine. Since oxalate is found in many foods it has frequently been assumed that urinary oxalate is largely, if not entirely, of dietary origin. However, animal studies have shown that oxalate may arise endogenously, and glycine, glyoxylic acid, glycolic acid (3) (4) (5) and ascorbic acid (6, 7) have been shown to be precursors of urinary or tissue oxalate under various circumstances.
The origin of urinary oxalate has long been an important physiological problem because of the high incidence of calcium oxalate urolithiasis in many parts of the world. Recently, interest in the biosynthesis of oxalate in man has been greatly stimulated by recognition of the syndrome of primary hyperoxaluria and oxalosis, a disorder in which excessive production of oxalate occurs and leads to deposition of calcium oxalate crystals in renal parenchyma and extrarenal tissues. Ascorbic acid has previously been shown to be a precursor of some urinary oxalate of normal man (6, 8) . In this paper glycine is shown to be a major precursor of urinary oxalate of normal and hyperoxaluric subjects. In one subject with primary hyperoxaluria, glycine incorporation into urinary oxalate was excessive, whereas in another subject with an inconstant hyperoxaluria, glycine incorporation was not abnormal. Measurements of the miscible pool of oxalate and of the rate of its turnover have been made by conventional isotopic dilution techniques, and a gross expansion of the miscible pool of oxalate demonstrated in a hyperoxaluric subject.
EXPERIMENTAL METHODS
Materials. Glycine I-C14, specific activity 2.2 mc per mmole, and oxalic acid 1,2-C"4, specific activity 2.6 mc per mmole, both of radiopurity > 99 per cent, were purchased from Isotopes Specialties Co. Burbank, Calif.
Control subjects. Control subj ects were hospitalized * Supported in part by a grant (A-1391) from the United States Public Health Service. Preliminary reports of this work have appeared (1, 2) . patients without known metabolic, gastrointestinal or genitourinary disease, in whom routine tests [urinalysis, blood urea nitrogen (BUN), phenolsulfonphthalein (PSP) excretion] disclosed no evidence of renal disease. They were permitted a regular hospital diet except that foods of high oxalate content [cocoa, chocolate, tea, rhubarb, beets and spinach (9) ] were withheld for a few days before and during the study period. In two subjects oxalate and hippurate were isolated simultaneously, from successive 2-hour urine samples. Two hours after ingestion of labeled glycine, and at 4-hour intervals for 3 additional doses, the subjects ingested 3 g of sodium benzoate, so as to insure a large urinary output of hippuric acid.
Urine specimens were collected in clean glass jugs containing 5 ml of concentrated HCI. Respiratory CO. was collected in carbonate-free, 1 N sodium hydroxide and precipitated as barium carbonate.
All counting was done in stainless steel planchets in a Robinson gas-flow counter (10) . Calcium oxalate samples varied in mass from 4 to 36 mg and were corrected for self-absorption to a standard mass of 22 mg per planchet (1.54 sq cm). Barium carbonate samples were counted in infinite thickness. Hippuric acid samples weighed from 5 to 15 mg and were corrected for self-absorption to a standard mass of 3.3 mg per planchet. Appropriate conversion factors were employed for comparison of counting values of glycine, oxalic acid, calcium oxalate and hippuric acid when required.
Isolation of oxalate from ulrine. Each urine sample was filtered through Whatman no. 42 paper in a Buchner funnel if any cloudiness or precipitate was grossly visible, and aliquots were taken for determination of oxalate by the method of Archer, Dormer, Scowen and Watts (11) . Thirty mg of oxalic acid dihydrate was added to the remainder of each urine specimen as carrier and the volume reduced to approximately 20 ml under reduced pressure at 30' C. The pH was adjusted to 5.5 with 8 N ammonium hydroxide, and 5 ml of 5 per cent CaCl, was then added. The samples were stored at 40 C overnight, centrifuged, and the supernatant solution discarded.
Calcium oxalate was then purified by a slight modification of the method of Burns, Burch and King (12) . The precipitate was washed 2 or 3 times with 4 ml of 0.35 N NH4OH, to remove colored impurities, and dissolved in 6 ml of 1 N sulfuric acid; after centrifugation the residue was discarded. The supernatant was placed in a glass microextractor 1 and extracted continuously with 100 ml of ether for at least 6 hours. At the end of the extraction period 10 ml of distilled water was added to the flask and the ether evaporated on a steam bath. The aqueous phase was transferred to a 40 ml conical centrifuge tube and the pH was adjusted to 5.5 with 8 N ammonium hydroxide. Calcium oxalate was reprecipitated by addition of 5 ml of 5 per cent CaCl2. The sample was stored overnight in the cold, centrifuged, and the supernatant discarded. The precipitate was dissolved in 1 N HCl, treated with Darco, filtered, and recrystallized by adjustment of the pH to 5.5 and addition of 5 ml of 5 per cent CaCl,. The last procedure was repeated several times.
The samples were dried at 80' C in a vacuum oven, ground with a stout glass rod in acetone, and transferred by pipet to a tared stainless steel planchet for counting.
Isolation of hippuric acid fromii urine. Urinary hippuric acid was isolated according to Quick (13) and purified by treatment with Darco and by repeated recrystallizations from hot water (14) . The The cumulative incorporation of C14 into urinary oxalate (Figure 2 ) ranged from 0.027 to 0.081 per cent (mean, 0.051 per cent) of the administered dose of glycine 1-C14 in five control subjects.
In two control subjects who received load doses of sodium benzoate beginning 2 hours after ingestion of glycine (Figure 3) , urinary oxalate was significantly more highly labeled than was urinary hippurate between 2 and 10 hours. Both substances exhibited typical die-away enrichment curves in both subjects.
These studies establish that glycine serves as a precursor of at least some of the urinary oxalate in normal man, and suggest 1) that relatively little dilution occurs between glycine and oxalate, 2) that the miscible pool of oxalate is small, and 3) that the turnover of the oxalate pool is rapid. Meas about 60 per cent of (aIi), and therefore the measurements of oxalate and of specific activity in the initial samples are critical to this correction. Table I shows that the calculated miscible pool of oxalate (expressed as oxalic acid dihydrate) ranged from 4.9 + 0.7 to 8.6 1.1 mg in three control subjects. The biological half-time of the pool ranged from 2.2 + 0.3 to 2.8 0.3 hours. The calculated daily turnover of oxalate in these three control subjects ranged from 34.1 + 6.7 to 63.8 + 11.3 mg per day. In each case the value of urinary oxalate on the day of the study fell within 2 SD of the calculated turnover.
Physiological disposition of oxalate in man
In three studies on control subjects and in two studies on N.M., a hyperoxaluric subject (see below), from 89 to 99 per cent of the injected oxalate 1,2-C14 was recovered unchanged in urine in 36 hours.
Respiratory CO, was collected at frequent intervals for 6 hours from two control subjects who had received 1 ,tc of oxalate-C14 intravenously and orally, respectively. In both cases all samples of CO2, counted as barium carbonate, were devoid . e e 00 t OO into urinary oxalate was 0.047 per cent, a value X .11 0\^*= ,4
close to the mean of those obtained in the control subjects (Figure 2 ). (4, 18, 19) and the present studies in man have shown that labeled oxalate is not significantly converted to respiratory CO2, and that an intravenous tracer of labeled oxalate is almost quantitatively excreted in urine.
Biosynthesis of oxalate. Ratner, Nocita and Green (3), Weinhouse and Friedmann (4), and Nakada and Weinhouse (5) have shown in animal studies in vivo and in vitro that glycine may be converted to oxalic acid, via glyoxylic acid. Glycine is converted to glyoxylic acid by glycine oxidase, and possibly as a by-product of transamination with a-ketoglutaric acid, a reaction whose equilibrium, however, lies far toward glycine. Glyoxylic acid is converted to oxalic acid by enzymes which are less well understood. One may be xanthine (aldehyde) oxidase (20) ; another, possibly a mutase, also exists (3). Glyoxylic acid is the only known direct precursor of oxalic acid in mammalian systems. Glycolic acid is readily converted to glyoxylic acid by a flavoprotein, glycolic oxidase (21) , and sparingly by lactic dehydrogenase and DPN (5) . The pathway by which ascorbic acid (4, 16) (25) studied a single control subject with glycine 1-C13, and concluded that at least half of the urinary oxalate was not derived from glycine in this subject.
In the present studies urinary oxalate was labeled considerably in excess of urinary hippurate. When no sodium benzoate is administered, urinary hippurate and urinary free glycine are comparably labeled within a few hours following administration of glycine N'5 or C13 (25) . The work of Gray and Neuberger (26) and of Arnstein and Neuberger (27) suggests that large doses of benzoate stimulate synthesis de novo of new glycine, or mobilize glycine from pools not ordinarily in rapid equilibrium with the pool from which hippurate derives its glycine. Benzoate loading probably explains why hippurate glycine was less highly labeled than oxalate in the present studies, whereas in the studies of Crawhall and associates (25) free glycine (and presumably hippurate also) was more highly labeled than was oxalate. Finally, the studies reported herein offer additional evidence for the existence of multiple metabolic pools of glycine in poor equilibrium one with another, as previously suggested by studies of a number of other workers (14, 27, 28) .
The miscible pool of oxalate and its biological turnover. The isotopic dilution technique for determination of the pool and turnover of a substance is based upon a number of assumptions and is subject to limitations which have been discussed in detail previously (29) . In the present study the major limitations are two: 1) the relatively large fraction of the injected tracer which is rapidly excreted in urine, and 2) the small quantity of oxalate present in 2-or 4-hour urine specimens. The first problem has been approached by eliminating from calculations the labeled oxalate which was excreted without mixing with the pool. The second problem was minimized by employing the average of replicate analyses.
The values shown in Table I for the miscible pool, biological half-time and turnover of oxalate in the body are in reasonably close agreement in three control subjects. The turnover values are in satisfactory agreement with urinary excretion data, although the turnover values tended to be a little larger, both in controls and in the hyperoxaluric subject. Animal studies suggest that some endogenous oxalate is excreted in the feces, but the urinary recovery of labeled oxalate of 94 per cent suggests that nonrenal excretion of en-dogenous oxalate is not a large fraction in normal subjects. Since only 90 per cent of oxalate C14 was recovered in N.M. when her oxalate pool was large, whereas 99 per cent was recovered when it was small, the possibility remains that a larger fractional nonrenal disposal of oxalate occurs in the presence of expanded body stores of oxalate.
Hyperoxaluria. In C.B., the incorporation of glycine 1-C14 into urinary oxalate was 0.22 per cent, a value about fourfold greater than the mean control value. This patient's urinary oxalate excretion was four-to fivefold greater than the mean normal value. Thus it appears that about the same percentage of urinary oxalate was derived from glycine in C.B. as in controls. Crawhall, Scowen and Watts (28) reached a similar conclusion in two hyperoxaluric subjects given glycine 1-C13. These results, considered together with evidence in vitro that oxalate synthesis from glycine becomes appreciable only when the glyoxylic acid pool is greatly expanded, suggest that a block in glyoxylic acid metabolism may exist in primary hyperoxaluria, possibly of glyoxylicglutamic transaminase (30) or of glyoxylic dehydrogenase (31) . Either block ( Figure 6 ) could account for overproduction of oxalate from more than one precursor of its obligatory intermediary, glyoxylic acid (32) .
In N.M. the incorporation study was performed at a time when the miscible pool and the daily excretion of oxalate were declining and approaching normal values (Day 5). The metabolic process which had led to hyperoxaluria had inadvertently been corrected, and the possibility that oxalate had previously been overproduced from glycine is not excluded. 
